Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ENAVATE SCIENCES GP, LLC (CIK 1953107) reported $351.5M across 6 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: SION ($99.3M, 28.26%), IMNM ($79.0M, 22.48%), ZBIO ($76.6M, 21.80%), CMPX ($41.2M, 11.72%), ($23.5M, 6.69%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SION | SIONNA THERAPEUTICS INC | $99.3M | 28.26% | 2.5M | Hold |
| 2 | IMNM | IMMUNOME INC | $79.0M | 22.48% | 3.6M | Trimmed |
| 3 | ZBIO | ZENAS BIOPHARMA INC | $76.6M | 21.80% | 3.9M | Hold |
| 4 | CMPX | COMPASS THERAPEUTICS INC | $41.2M | 11.72% | 7.8M | Hold |
| 5 | BRIDGEBIO ONCOLOGY THERAPEUT | $23.5M | 6.69% | 2.6M | Hold | |
| 6 | UPB | UPSTREAM BIO INC | $22.1M | 6.30% | 2.5M | Hold |
| 7 | CAMP | CAMP4 THERAPEUTICS CORP | $9.7M | 2.75% | 2.2M | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31